New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Array Biopharma Inc (NASDAQ:ARRY), BIOLASE Inc (NASDAQ:BIOL), Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS), Triangle Petroleum Corporation (NYSEMKT:TPLM)
Array Biopharma Inc (NASDAQ:ARRY) showed a volume of 1.35 million shares by the end of last trade whereas the average volume of the stock remained 1.76 million shares. The stock opened the session at $5.23 but then moved to $5.30. At that price, the stock showed a positive performance of 1.82%. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways.
Will ARRY Continue To Move Higher? Find Out Here
BIOLASE Inc (NASDAQ:BIOL) opened the session at $2.95 and closed the session at $3.14. The stock showed a positive performance of 9.03% in previous trading session. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 619,951.00 shares. BIOLASE, Inc., formerly BIOLASE Technology, Inc. is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications in a minimally invasive manner.
For How Long BIOL will fight for Profitability? Read This Trend Analysis report
Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS) opened the session at $4.58 and closed the session at $4.50. The stock showed a negative performance of -1.75% in previous trading session. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 268,143.00 shares. The beta of the stock remained 2.05. Sunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The Company is focuses primarily on the development of vosaroxin for the treatment of acute myeloid leukemia (AML). Vosaroxin is a anti-cancer quinolone derivative (AQD). AQDs have been shown to mediate anti-tumor activity by targeting mammalian topoisomerase II,
Why Should Investors Buy SNSS After the Recent Fall? Just Go Here and Find Out
Triangle Petroleum Corporation (NYSEMKT:TPLM) the stock decreased -0.97% and finished the session at $8.16. Traded with volume of 1.32 million shares in the prior session and the average volume of the stock remained 1.77 million shares. The beta of the stock remained 1.81. Triangle Petroleum Corporation (Triangle) is an exploration and production company ,which is focused on the development of unconventional shale oil and natural gas resources in the Bakken Shale and Three Forks formations in the Williston Basin of North Dakota and Montana. As of January 31, 2012, the Company owned approximately 83,000 net acres in McKenzie and Williams Counties of North Dakota and Roosevelt and Sheridan Counties of Montana.
Will TPLM Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)